<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00211562</url>
  </required_header>
  <id_info>
    <org_study_id>Omega-3 Fatty Acids</org_study_id>
    <nct_id>NCT00211562</nct_id>
  </id_info>
  <brief_title>Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids</brief_title>
  <official_title>Reduction of Body Weight in Olanzapine Treated Schizophrenia Patients by Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Augusta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical Service Line ABRC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Augusta University</source>
  <brief_summary>
    <textblock>
      This research study helps to demonstrate that adding vitamins and fats (nutritional
      supplements) to a diet will help reduce body weight and improve the lipid profile. This will
      be done by examining the body weight and chemicals in the blood. The chemicals are the result
      of the brain using the fat that subjects eat in their diet. Some medications may also change
      the amount of these chemicals in a person's blood.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To demonstrate that supplementation of antioxidants and omega-3 fatty acids will improve
      clinical outcome including cognitive performance in olanzapine treated patients.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>October 2005</start_date>
  <primary_completion_date type="Actual">January 2006</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PANSS</measure>
    <time_frame>2003-2006</time_frame>
    <description>Study completed in 2006. PI no longer with the institution. Study was closed accordingly to the HAC.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>BMI</measure>
    <time_frame>2003-2006</time_frame>
    <description>BMI match height and weight.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood samples</measure>
    <time_frame>2003-2006</time_frame>
    <description>Samples analyzed, PI analyzed and published. PI no longer with the institution.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive assessments</measure>
    <time_frame>2003-2006</time_frame>
    <description>BACS assessment. Data analyzed and published by the PI.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Olanzapine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Omega 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin E +C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Olanzapine, Omega 3, Vitamin E+C</intervention_name>
    <description>No adverse event nor SAE noted.</description>
    <arm_group_label>Olanzapine</arm_group_label>
    <arm_group_label>Omega 3</arm_group_label>
    <arm_group_label>Vitamin E +C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 to 55

          -  VA outpatient

          -  Diagnosis of schizophrenia by DSM-IV criteria

          -  Active treatment with olanzapine

          -  Medically healthy

        Exclusion Criteria:

          -  Diagnosis of MR

          -  MMSE score of &lt; 26

          -  Not on a stable dose of olanzapine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Buckley, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA MC/Medical College of Georgia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Medical Center</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov</url>
  </link>
  <reference>
    <citation>Jones B, Basson BR, Walker DJ, Crawford AM, Kinon BJ. Weight change and atypical antipsychotic treatment in patients with schizophrenia. J Clin Psychiatry. 2001;62 Suppl 2:41-4. Review.</citation>
    <PMID>11232752</PMID>
  </reference>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>October 23, 2012</last_update_submitted>
  <last_update_submitted_qc>October 23, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 24, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>weight gain</keyword>
  <keyword>weight gain supplementation</keyword>
  <keyword>antioxidants</keyword>
  <keyword>olanzapine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
    <mesh_term>Olanzapine</mesh_term>
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

